Caledonia approves quarterly dividend
ST HELIER, Jersey, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc ("Caledonia" or "the Company") (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) is pleased to announce that the board of directors has approved a quarterly dividend of 14 United States cents (US$0.14) on each of the Company's shares.
The relevant dates relating to the dividend are as follows:
-- Ex-dividend date VFEX: November 20, 2024 -- Ex-dividend date AIM: November 21, 2024 -- Ex-dividend date NYSE American: November 22, 2024 -- Record date: November 22, 2024 -- Payment date: December 6, 2024
Shareholders with a registered address in the UK will be paid in Sterling.
Caledonia's Dividend Policy
Caledonia's strategy to maximise shareholder value includes a quarterly dividend policy which the Board adopted in 2014. The Board will consider future dividends as appropriate and in line with other investment opportunities and its prudent approach to risk management.
Enquiries:
Caledonia Mining Corporation Plc Mark Learmonth Tel: +44 1534 679 800 Camilla Horsfall Tel: +44 7817 841 793 Cavendish Capital Markets Limited (Nomad and Joint Broker) Adrian Hadden Pearl Kellie Tel: +44 207 397 1965 Tel: +44 131 220 9775 Panmure Liberum (Joint Broker) Tel: +44 20 3100 2000 Scott Mathieson/Matt Hogg Camarco, Financial PR (UK) Tel: +44 20 3757 4980 Gordon Poole 3PPB (Financial PR, North America) Tel: +1 917 991 7701 Patrick Chidley Tel: +1 203 940 2538 Paul Durham Curate Public Relations (Zimbabwe) Tel: +263 77802131 Debra Tatenda IH Securities (Private) Limited (VFEX Sponsor - Zimbabwe) Lloyd Mlotshwa Tel: +263 (242) 745 119/33/39
This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation $(EU)$ No. 596/2014 ("MAR") as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
(END) Dow Jones Newswires
November 11, 2024 02:10 ET (07:10 GMT)
Comments